M(3) muscarinic receptors mediate contraction of human urinary bladder. - Wikidata - wikimedia - TriplyDB

M(3) muscarinic receptors mediate contraction of human urinary bladder.

M(3) muscarinic receptors mediate contraction of human urinary bladder.

http://www.wikidata.org/entity/Q42040357

about

An investigation of dose titration with darifenacin, an M3-selective receptor antagonist.Age-dependent contribution of Rho kinase in carbachol-induced contraction of human detrusor smooth muscle in vitro AE9C90CB: a novel, bladder-selective muscarinic receptor antagonist for the treatment of overactive bladder.Nerve-released acetylcholine contracts urinary bladder smooth muscle by inducing action potentials independently of IP3-mediated calcium release.Pharmacologic characteristics of bladder micturition function in anesthetized mice Pharmacodynamic effects of darifenacin, a muscarinic M selective receptor antagonist for the treatment of overactive bladder, in healthy volunteers.Muscarinic receptors in the bladder: from basic research to therapeutics.Darifenacin: a muscarinic M3-selective receptor antagonist for the treatment of overactive bladder.Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing.Pharmacodynamics of propiverine and three of its main metabolites on detrusor contraction Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder The M2 muscarinic receptor mediates in vitro bladder contractions from patients with neurogenic bladder dysfunction.Potential therapeutic targets for the treatment of detrusor overactivity.M2 mediated contractions of human bladder from organ donors is associated with an increase in urothelial muscarinic receptors.Urinary Retention, Incontinence, and Dysregulation of Muscarinic Receptors in Male Mice Lacking Mras Darifenacin: a novel M3 muscarinic selective receptor antagonist for the treatment of overactive bladder.Current and emerging investigational medical therapies for the treatment of overactive bladder.Transdermal drug delivery treatment for overactive bladder.In vivo and in vitro pharmacological characterization of SVT-40776, a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder.Role of fesoterodine in the treatment of overactive bladder.Gene expression of muscarinic, tachykinin, and purinergic receptors in porcine bladder: comparison with cultured cells.Darifenacin for the treatment of overactive bladder.Muscarinic acetylcholine receptors as effector sites for present and future therapeutic applications: focus on non-neural cholinergic systems.Management of mixed urinary incontinence.Understanding clinic options for overactive bladder.New therapies in the treatment of overactive bladder.Phase II drugs that target cholinergic receptors for the treatment of overactive bladder.Differential pharmacological effects of antimuscarinic drugs on heart rate: a randomized, placebo-controlled, double-blind, crossover study with tolterodine and darifenacin in healthy participants > or = 50 years.A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder.Octodon degus, a new model to study the agonist and plexus-induced response in the urinary bladder.An investigation of factors predicting the type of bladder antimuscarinics initiated in Medicare nursing homes residents.The histopathologic, pharmacologic and urodynamic results of mesenchymal stem cell's injection into the decompensated rabbit's bladder.The effects of tolterodine on bladder-filling sensations and perception thresholds to intravesical electrical stimulation: method and initial results.Molecular characterization of M2 and M3 muscarinic receptor expression in bladder from women with refractory idiopathic detrusor overactivity.Antimuscarinic drugs for the treatment of female urinary incontinence.

P2860

Q30435897-B5B05D1C-12F2-46B9-B159-0BC1B7C11FE7 Q33823666-7EC8B7E5-D5CF-478D-B409-B4B12EF74A16 Q34112974-398A9E77-A100-4B79-8C9E-D28EA936D96C Q34150201-E7032B16-74D2-424E-A6DB-C1105C6FBBE6 Q34406969-CAA0B687-38F6-4834-B723-16CC63E511D5 Q34561743-84405343-59DA-4902-8A4D-004C0D67DE6F Q34564708-E5502605-FDAB-4EAE-9761-7E4AEE49C25F Q34575850-0BFC41A5-AA73-4481-8067-BAB8BAD02F17 Q35048803-33A8B7F6-3B83-4A33-B951-5D5AE812CE24 Q35048983-AA804935-EEF2-4FE6-B396-CC5FAD381966 Q35546189-526648FC-3C9E-4211-932A-56C9C403181A Q35743183-29DCCAC4-EF89-4E59-B7F5-137544FCE379 Q35753357-3EFF7058-0FE4-4BE4-B2CE-E85A370E6BD9 Q35801020-A29AF09D-0900-41CB-8F97-7138C8403ED1 Q35827050-59A9886B-5C81-4A44-BBD2-8E54B4E84498 Q35925590-545F0218-F477-4793-9A37-202C4E503316 Q36568728-75B18F5E-8D5C-4467-AB35-945A372DFBFC Q36642882-A91C9EE0-9781-440A-890F-C200FB515A7D Q37230811-972B817D-430C-469C-AE9C-61186559D5F0 Q37283542-FF4DDF53-123F-4170-A4A0-8E7DEA5C8B0A Q37348576-15ED098B-3A83-4A92-B349-4184E8CC7AC8 Q37608354-2F7C5E90-DA8F-49E3-991A-37C9418FEA9A Q37689776-2BA5A633-766B-4823-8747-A8D826B32FC0 Q38039168-2C0C3EF1-A69E-4E4D-8850-3910B36A9901 Q38118177-B733DA61-5343-49FB-9244-A0CE2F79090A Q38124045-43AB828E-C2C1-43EF-898B-CA32FEA859DF Q38217760-14B2EB30-3867-437B-B64C-536E2A463054 Q46334125-0DA47A77-9D16-4A50-852C-435FDB4DCB11 Q46445206-7D3671BB-EFCB-4CE1-B5E9-BB34D9E62FED Q46478236-B5DDF044-2406-4DC9-8E8D-1F206D8D1037 Q47143545-A5BB4151-A2D4-491C-B35A-6C4FA1DDD574 Q50494559-693CE03F-BA2A-46E7-ABF7-4B88B5B7D22D Q51743958-87BAABDB-FFF0-48A9-8F98-9FC265972042 Q51757224-F37B1D46-B6CC-43AF-BA84-FE35D159A698 Q51817526-697C0313-E5F4-4E8F-99DC-79BCD9115D18

P2860

M(3) muscarinic receptors mediate contraction of human urinary bladder.

http://www.wikidata.org/entity/Q42040357

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

M(3) muscarinic receptors mediate contraction of human urinary bladder.

@en

type

label

M(3) muscarinic receptors mediate contraction of human urinary bladder.

@en

prefLabel

M(3) muscarinic receptors mediate contraction of human urinary bladder.

@en

P1433

Q42040357-C5C2AB48-97A6-4F82-B5D5-6441B612D3EB

P1476

Q42040357-FA8A50F5-EDD3-45D6-BB2E-45659EAE548A

P2093

Q42040357-857F161F-FA55-4514-A489-04B55FA10B6D

Q42040357-8E1A1D44-FB04-4F37-82F6-12F67125C177

Q42040357-A4B04B85-A131-470A-BEBA-037901A65EC4

Q42040357-CD491EC4-8552-4A2A-B55A-20CBC0510486

Q42040357-EC7E2D0B-E92E-44C5-A612-38927CE07B95

P2860

Q42040357-029B5B19-9245-4F12-9A0C-DD153663D143

Q42040357-035D7EDF-FC56-4816-9A38-2DD210BCDE92

Q42040357-15CCD63B-1045-4A17-96CD-23B432391391

Q42040357-2D458422-66CE-42DE-9F17-535FBADBE0B8

Q42040357-33FF090C-0435-4DE0-B28E-1BA143FE7972

Q42040357-4215BA4C-C715-4532-A2B2-DA4A836100D1

Q42040357-42D65EEC-5CB9-4D21-AEFD-E4FD99E772B6

Q42040357-65EE5FEF-752A-4AE9-946F-726EC1562204

Q42040357-6EF11C6B-4B6C-4418-9115-31D5106BD2B5

Q42040357-92746C4A-2D07-4D78-BB14-2128D9F1E0DF

P304

Q42040357-44F037E8-CD2A-4249-A693-48B4AFF6C611

P31

Q42040357-19415E31-B55A-4102-BB17-78BE81EBDFD0

P356

Q42040357-1E00FC97-59AB-42DB-BFEE-669B8F5A7E85

P407

Q42040357-DFE689CF-35AB-4D76-9CFA-0C3464FF0D9D

P433

Q42040357-721BF046-1D24-421F-93B6-5F62B25BE00E

P478

Q42040357-F7EE9E71-2D6F-4DDB-9F7A-A2D920C9EF74

P577

Q42040357-D7175EA4-9050-4E8D-A114-3293E9AAE1CD

P5875

Q42040357-4BECBA04-5FAB-471C-A82B-273E900383A0

P698

Q42040357-A8034565-7716-4A04-8E71-6C35BCAE032D

P932

Q42040357-7DC45299-72A4-4C64-A739-6C4C2D25545B

P356

P1433

British Journal of Pharmacology

P1476

M(3) muscarinic receptors mediate contraction of human urinary bladder.

@en

P2093

Charlotte Fetscher

http://www.w3.org/2001/XMLSchema#string

Marina Fleichman

http://www.w3.org/2001/XMLSchema#string

Martin C Michel

http://www.w3.org/2001/XMLSchema#string

Martina Schmidt

http://www.w3.org/2001/XMLSchema#string

Susanne Krege

http://www.w3.org/2001/XMLSchema#string

P2860

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

Pharmacological characterization of muscarinic receptors in mouse isolated urinary bladder smooth muscle

Pharmacological characterization of muscarinic receptors in dog isolated ciliary and urinary bladder smooth muscle

Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo

Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype

Some quantitative uses of drug antagonists

The overactive bladder.

Pharmacological characterization of muscarinic receptors in rabbit isolated iris sphincter muscle and urinary bladder smooth muscle

Influence of gender and the oestrous cycle on in vitro contractile responses of the rat urinary bladder to cholinergic stimulation

The role of M(2)-muscarinic receptors in mediating contraction of the pig urinary bladder in vitro

P304

641-643

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJP.0704781

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

136

http://www.w3.org/2001/XMLSchema#string

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11288444

http://www.w3.org/2001/XMLSchema#string

P698

12086973

http://www.w3.org/2001/XMLSchema#string

P932

1573406

http://www.w3.org/2001/XMLSchema#string